Post-traumatic Stress Disorder Treatment Market by Drug Class (Antipsychotics, Antidepressants, Anti-anxiety, Others), Demographics (Geriatric, Pediatric, Adult), Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospital Pharmacy, Others), and by Region - Global Forecast to 2022-2033

The post-traumatic stress disorder treatment market size is estimated to be USD 997.54 million in 2022 and is expected to witness a CAGR of 4.95% during the forecast period 2023-2033. Strong late-stage product pipelines, growing demand for better treatment choices and rising R&D for the creation of novel treatment therapies are factors contributing to the market growth. Furthermore, increase in post-traumatic stress disorder (PTSD) cases around the world and rise in prevalence of post-traumatic stress disorder However, high price of therapy is expected to hinder the growth.

Rise in prevalence of post-traumatic stress disorder is expected to propel the market growth during the projected period. One in 13 persons will experience post-traumatic stress disorder at some point in their lives due to the rise in its prevalence. 70% of adult Americans experience at least one traumatic event, and 20% of those people continue to develop PTSD as a result, according to an NCBI study. Since sexual assault and rape victims are the main cause of traumatic events, women are more likely than men to suffer from this disorder. Approximately 9.7% of women and 3.6% of men have it, respectively.

Growing demand for better treatment choices is predicted to fuel the market growth during the forecast period. A lucrative potential for market growth is being formed during the forecast period as a consequence of the growing demand for better treatment choices driving R&D innovation and the introduction of new therapeutic medications. For instance, the Brexpiprazole and Zoloft Combination from Otsuka Pharmaceutical Development Inc. is currently undergoing phase 3 research for PTSD. Furthermore, the phase 2 clinical trials for Jazz Pharmaceuticals’ JZP150, Aptinyx’s NYX-783, and Bionomics’ BNC210 are expected to drive the expansion of the market during the projection period.

Segmentation

By Drug Class

The market is categorized into antipsychotics, antidepressants, anti-anxiety, and others. In 2022, the antidepressants segment accounted for the highest revenue share due to the fact that FDA-approved SSRIs (selective serotonin reuptake inhibitors) driving the space, including Sertraline (Zoloft) and Paroxetine (Paxil). They are advised as the initial course of treatment for PTSD. Serzone (nefazodone), Nardil (phenelzine), and Tofranil (imipramine), some off-label antidepressants with a high presence in the area to treat the disease. In addition, major players are proactively launching projects including partnerships, expansion, and collaborations to create pharmaceuticals and advance in the industry. For instance, H. Lundbeck A/S and Sun Pharmaceutical Industries Ltd. agreed into a licence agreement in March 2022 for the antidepressant medication Vortioxetine. The main players are also working on and developing combination therapy, such as antidepressant drugs, to treat the disease. For instance, the phase 3 trials for the Brexpiprazole and Zoloft Combination by Otsuka Pharmaceutical are expected to propel the market.

By Demographics

The market is categorized into geriatric, pediatric, and adult. In the global market, the adult segment accounted for the largest revenue share in 2022 owing to majority of patients falling into this age group, rise in disorder cases among adults, and surge in traumatic experiences. The majority of the population exhibits severe, moderate, or mild symptoms of impairment. The research study estimates that in the United States in 2021, mild impairment impacted approximately 30% of patients, substantial impairment affected about 33% of patients, and serious impairment impacted about 36% of patients. Moreover, PTSD in adults is also influenced by childhood trauma. In addition, as indicated, adult women have a higher frequency of PTSD at 5.2% compared to adult men at 1.8%. As a result, it is anticipated that the segment will continue to dominate during the projection period.

By Distribution Channel

The market is segmented into retail pharmacy, online pharmacy, hospital pharmacy, and others. In 2022, the retail pharmacy segment accounted for the largest revenue share owing to fact that retail pharmacies are convenient for the majority of prescriptions, particularly in the context of homecare. Treatment, control, and management of post-traumatic stress disorder require both short- and long-term assistance from pharmaceuticals, which promotes the expansion of retail pharmacies. The others segment is anticipated to exhibit a significant CAGR throughout the projection period. The availability of online pharmacy platform promotes buying convenience. The convenience and flexibility of home delivery have boosted the trend of online buying, which is fueling the segment’s growth and generating revenues.

Regional Markets

In 2022, North America region accounted for the highest revenue in the post-traumatic stress disorder market and is expected to maintain its dominance during the forecast period. This is attributed to the growing incidence of PTSD and expanding patient awareness of mental health. For instance, according to data and facts regarding PTSD, the frequency of the disorder among adults over the age of 18 in the U.S. was estimated to be 3.6%. The growth is being fueled by rising healthcare costs and the presence of significant companies in the region. Proactive government initiatives and advanced therapeutic choices, which are projected to see new approvals and launches during the forecast period, also support regional growth. Asia Pacific is predicted to experience the fastest growth rate in the upcoming years. The significant growth rate can be attributed to the increasing disorder burden and the growing number of individuals seeking medical attention for mental health. The market in the region is anticipated to be driven by positive improvements such government healthcare benefits, higher public awareness, and a greater desire among people to seek medical care.

Competitor Insights

Some of the key players operating in the post-traumatic stress disorder market are Merck KGaA, Bionomics, Aurobindo Pharma Limited, GlaxoSmithKline plc., Lupin Limited, Otsuka Pharmaceutical Development, Aptinyx, Jazz Pharmaceuticals, Pfizer, Inc., and AstraZeneca.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

  • For instance, Mydecine Innovations Group Inc., Combat Stress, and King’s College London announced a contract to work together to treat PTSD with the psychotherapy drug psilocybin in January 2022.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including drug class, demographics, and distribution channel from 2023 to 2033.

Report Scope:

Key Parameters Details
Market size in 2022
  • USD 997.54 Million
CAGR
  • 4.95%
Base Year
  • 2022
Forecast Period
  • 2023-2033
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • COVID-19 impact analysis
Segment Market Scope
  • Drug Class
  • Demographics
  • Distribution Channel
Regional Market Scope
  • North America
    (U.S. and Canada)
  • Europe
    (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific
    (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America
    (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA
    (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • Other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Segmentation: Post-traumatic Stress Disorder Treatment Market Report 2022 – 2033

Drug Class (Revenue, USD Million), 2022 – 2033

  • Antipsychotics
  • Antidepressants
  • Anti-anxiety
  • Others

Demographics (Revenue, USD Million), 2022 – 2033

  • Geriatric
  • Pediatric
  • Adult

Distribution Channel (Revenue, USD Million), 2022 – 2033

  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
  • Others

By Region (Revenue, USD Million), 2022 – 2033

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents: Post-traumatic Stress Disorder Treatment Market 2022-2033

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Framework
      1. Research Demographics ls
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Demographics l
  1. Introduction: Post-traumatic Stress Disorder Treatment
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. SWOT Analysis
  2. COVID-19 Impact Analysis: Post-traumatic Stress Disorder Treatment Market
  3. Market Analysis by Drug Class
    1. Support & Maintenance
      1. Support & Maintenance Market Forecast, 2022-2033(USD Million)
    2. Training
      1. Training Market Forecast, 2022-2033(USD Million)
    3. Education
      1. Education Market Forecast, 2022-2033(USD Million)
    4. Medical Necessity
      1. Medical Necessity Market Forecast, 2022-2033(USD Million)
  1. Market Analysis by Demographics
    1. Web & Cloud
      1. Web & Cloud Market Forecast, 2022-2033(USD Million)
    2. On premise
      1. On premise Market Forecast, 2022-2033(USD Million)
  1. Market Analysis by Distribution Channel
    1. HCIT Outsourcing Companies
      1. HCIT Outsourcing Companies Market Forecast, 2022-2033(USD Million)
    2. Healthcare Providers
      1. Healthcare Providers Market Forecast, 2022-2033(USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends Analysis
  2. North America Post-traumatic Stress Disorder Treatment Market
    1. North America Post-traumatic Stress Disorder Treatment Market
      1. North America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
        2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
      2. S. Post-traumatic Stress Disorder Treatment Market
        1. S. Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
          2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        2. Canada Post-traumatic Stress Disorder Treatment Market
          1. Canada Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
            2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
  1. Europe Post-traumatic Stress Disorder Treatment Market
    1. Europe Post-traumatic Stress Disorder Treatment Market
      1. Europe Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
        2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
      2. Germany Post-traumatic Stress Disorder Treatment Market
        1. Germany Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
          2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        2. UK Post-traumatic Stress Disorder Treatment Market
          1. UK Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
            2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          2. France Post-traumatic Stress Disorder Treatment Market
            1. France Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
              2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
              3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
            2. Spain Post-traumatic Stress Disorder Treatment Market
              1. Spain Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
                3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
              2. Italy Post-traumatic Stress Disorder Treatment Market
                1. Italy Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                  2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
                  3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
                2. Rest of Europe Post-traumatic Stress Disorder Treatment Market
                  1. Rest of Europe Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                    2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
                    3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
  1. Asia Pacific Post-traumatic Stress Disorder Treatment Market
    1. Asia Pacific Post-traumatic Stress Disorder Treatment Market
      1. Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
        2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
      2. Japan Post-traumatic Stress Disorder Treatment Market
        1. Japan Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
          2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        2. China Post-traumatic Stress Disorder Treatment Market
          1. China Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
            2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          2. India Post-traumatic Stress Disorder Treatment Market
            1. India Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
              2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
              3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
            2. South Korea Post-traumatic Stress Disorder Treatment Market
              1. South Korea Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
                3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
              2. Australia Post-traumatic Stress Disorder Treatment Market
                1. Australia Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                  2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
                  3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
                2. Rest of Asia Pacific Post-traumatic Stress Disorder Treatment Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                    2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
                    3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
  1. Latin America Post-traumatic Stress Disorder Treatment Market
    1. Latin America Post-traumatic Stress Disorder Treatment Market
      1. Latin America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
        2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
      2. Brazil Post-traumatic Stress Disorder Treatment Market
        1. Brazil Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
          2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        2. Mexico Post-traumatic Stress Disorder Treatment Market
          1. Mexico Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
            2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          2. Argentina Post-traumatic Stress Disorder Treatment Market
            1. Argentina Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
              2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
              3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
            2. Rest of Latin America Post-traumatic Stress Disorder Treatment Market
              1. Rest of Latin America Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
                2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
                3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
  1. MEA Post-traumatic Stress Disorder Treatment Market
    1. MEA Post-traumatic Stress Disorder Treatment Market
      1. MEA Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
        2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
      2. GCC Post-traumatic Stress Disorder Treatment Market
        1. GCC Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
          2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        2. South Africa Post-traumatic Stress Disorder Treatment Market
          1. South Africa Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
            2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          2. Rest of MEA Post-traumatic Stress Disorder Treatment Market
            1. Rest of MEA Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Drug Class, 2022-2033(USD Million)
              2. Market Size and Forecast by Demographics,2022-2033 (USD Million)
              3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2022
    2. Major Recent Developments, 2019-2022
  2. Company Profiles
    1. Merck KGaA
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    2. Bionomics
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    3. Aurobindo Pharma Limited
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    4. GlaxoSmithKline plc.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    5. Lupin Limited
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    6. Otsuka Pharmaceutical Development
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    7. Aptinyx
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    8. Jazz Pharmaceuticals
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    9. Pfizer, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    10. AstraZeneca
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    14. Company14
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
  1. Conclusion
  2. Recommendations

Leave a comment

Your email address will not be published. Required fields are marked *

Select License Type

5 reasons to choose Quintana Research Reports

Our top-quality, real-time, accurate, and data-driven research aims at empowering the clients with actionable insights.

We deliver timely data-driven insights to help clients make informed decisions and achieve growth and success.

Our team of experts is available 24*7 to offer incisive analysis of the market for clients.

We offer comprehensive and bespoke marketing research as per clients’ requirements.

Our cost-effective and rapid research helps clients gain competitive intelligence, and uncover potential opportunities & threats.